series-b
Stage
About
LinqMed Inc. is a Japanese radiopharmaceutical startup developing next-generation radiotherapeutic drugs using copper radioisotopes for diagnosis and treatment of intractable cancers.
Explore LinqMed Inc.'s full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.